P3 Health Partners Inc.
PIII
$10.03
-$0.28-2.72%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 4.17% | 2.70% | 0.25% | -4.66% | -7.24% |
| Total Other Revenue | 391.71% | 85.84% | 78.61% | -- | -- |
| Total Revenue | 8.60% | 3.53% | 3.81% | -4.66% | -6.16% |
| Cost of Revenue | -14.51% | -9.68% | 3.86% | -7.99% | -3.78% |
| Gross Profit | 1,837.90% | 4,161.08% | -4.31% | 38.35% | -68.27% |
| SG&A Expenses | 38.16% | 2.34% | -4.77% | -18.14% | -13.24% |
| Depreciation & Amortization | -0.18% | 0.10% | -0.75% | -2.95% | -2.81% |
| Other Operating Expenses | -45.11% | 32.28% | 46.11% | -230.65% | -75.65% |
| Total Operating Expenses | -11.48% | -8.06% | 6.18% | -16.98% | -5.01% |
| Operating Income | 220.81% | 121.63% | -12.60% | 58.67% | -8.90% |
| Income Before Tax | 140.58% | 81.57% | -34.27% | 34.76% | -49.91% |
| Income Tax Expenses | -36.14% | -1,124.88% | -121.00% | 100.31% | 104.65% |
| Earnings from Continuing Operations | 135.84% | 106.87% | -28.31% | 32.46% | -51.75% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -135.22% | -107.65% | 27.88% | -32.77% | 39.09% |
| Net Income | 136.56% | 105.97% | -28.83% | 32.09% | -69.40% |
| EBIT | 220.81% | 121.63% | -12.60% | 58.67% | -8.90% |
| EBITDA | 577.49% | 272.05% | -15.05% | 72.82% | -35.27% |
| EPS Basic | 89.85% | 105.92% | 8.44% | 32.71% | -41.66% |
| Normalized Basic EPS | 183.60% | -109.27% | 30.42% | 46.24% | -267.99% |
| EPS Diluted | 89.85% | 105.07% | -58.52% | 38.40% | 15.44% |
| Normalized Diluted EPS | 183.60% | 18.25% | -1.29% | 45.31% | -280.13% |
| Average Basic Shares Outstanding | 2.91% | 0.86% | 40.71% | 0.93% | 19.58% |
| Average Diluted Shares Outstanding | 2.91% | 158.19% | 349.48% | -0.79% | 15.77% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |